TY - JOUR
T1 - Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine
T2 - A consensus paper on the present state of the science and the road ahead
AU - Ekhtiari, Hamed
AU - Tavakoli, Hosna
AU - Addolorato, Giovanni
AU - Baeken, Chris
AU - Bonci, Antonello
AU - Campanella, Salvatore
AU - Castelo-Branco, Luis
AU - Challet-Bouju, Gaëlle
AU - Clark, Vincent P.
AU - Claus, Eric
AU - Dannon, Pinhas N.
AU - Del Felice, Alessandra
AU - den Uyl, Tess
AU - Diana, Marco
AU - di Giannantonio, Massimo
AU - Fedota, John R.
AU - Fitzgerald, Paul
AU - Gallimberti, Luigi
AU - Grall-Bronnec, Marie
AU - Herremans, Sarah C.
AU - Herrmann, Martin J.
AU - Jamil, Asif
AU - Khedr, Eman
AU - Kouimtsidis, Christos
AU - Kozak, Karolina
AU - Krupitsky, Evgeny
AU - Lamm, Claus
AU - Lechner, William V.
AU - Madeo, Graziella
AU - Malmir, Nastaran
AU - Martinotti, Giovanni
AU - McDonald, William M.
AU - Montemitro, Chiara
AU - Nakamura-Palacios, Ester M.
AU - Nasehi, Mohammad
AU - Noël, Xavier
AU - Nosratabadi, Masoud
AU - Paulus, Martin
AU - Pettorruso, Mauro
AU - Pradhan, Basant
AU - Praharaj, Samir K.
AU - Rafferty, Haley
AU - Sahlem, Gregory
AU - Salmeron, Betty jo
AU - Sauvaget, Anne
AU - Schluter, Renée S.
AU - Sergiou, Carmen
AU - Shahbabaie, Alireza
AU - Sheffer, Christine
AU - Spagnolo, Primavera A.
AU - Steele, Vaughn R.
AU - Yuan, Ti fei
AU - van Dongen, Josanne D.M.
AU - Van Waes, Vincent
AU - Venkatasubramanian, Ganesan
AU - Verdejo-García, Antonio
AU - Verveer, Ilse
AU - Welsh, Justine W.
AU - Wesley, Michael J.
AU - Witkiewitz, Katie
AU - Yavari, Fateme
AU - Zarrindast, Mohammad Reza
AU - Zawertailo, Laurie
AU - Zhang, Xiaochu
AU - Cha, Yoon Hee
AU - George, Tony P.
AU - Frohlich, Flavio
AU - Goudriaan, Anna E.
AU - Fecteau, Shirley
AU - Daughters, Stacey B.
AU - Stein, Elliot A.
AU - Fregni, Felipe
AU - Nitsche, Michael A.
AU - Zangen, Abraham
AU - Bikson, Marom
AU - Hanlon, Colleen A.
N1 - Funding Information:
Xavier Noël is supported by a grant of the Belgian Fund for Scientific Research (grant PDR/OL T.0146.18 ). Anna E. Goudriaan and Renée S. Schluter are funded by an innovative VIDI grant awarded to AG (grant number 91713354 ) by the Netherlands Health Research Organization (ZonMW). Elliot Stein and Vaughn Steele are supported by the Intramural Research Program of the National Institute on Drug Abuse (NIDA), National Institutes of Health, Baltimore, Maryland and The Center on Compulsive Behavior . Antonio Verdejo-García is supported by Australian Medical Research Future Fund ( MRF1141214 ). Laurie Zawertailo received funding from Canadian Institutes of Health Research, Canadian Cancer Society, Ontario Ministry of Health , and Global Research Awards in Nicotine Dependence . Flavio Frohlich received funding from NIH , Bran and Behavior Research Foundation , Human Frontiers Science Program , Tal Medical , and the Neurocare Group . Shirley Fecteau is supported by the Canada Research Chair in Cognitive Neuroplasticity . Stacey Daughters is supported by the NIH/NIDA ( R01DA026424 ). Michael A. Nitsche receives funding from the German Research Foundation (DFG; SFB 1280 Project A6), and the German Federal Ministry of Education and Research (BMBF, GCBS grant 01EE1403C ). Coleen A. Hanlon received funding from the NIDA ( R01DA04447 ) and NIAAA ( P50AA010761 ). Vincent Van Waes is supported by the Fondation pour la Recherche en Alcoologie (FRA) and the Région Bourgogne Franche-Comté . Ganesan Venkatasubramanian is supported by the Swarnajayanti Fellowship Grant ( DST/SJF/LSA-02/2014-15 ) by the Department of Science and Technology, Government of India . Michael J. Wesley receives funding from the NIDA ( K01DA043652 ; R01DA045023 and R01DA047368 ).
Funding Information:
Xavier Noël is supported by a grant of the Belgian Fund for Scientific Research (grant PDR/OL T.0146.18). Anna E. Goudriaan and Renée S. Schluter are funded by an innovative VIDI grant awarded to AG (grant number 91713354) by the Netherlands Health Research Organization (ZonMW). Elliot Stein and Vaughn Steele are supported by the Intramural Research Program of the National Institute on Drug Abuse (NIDA), National Institutes of Health, Baltimore, Maryland and The Center on Compulsive Behavior. Antonio Verdejo-García is supported by Australian Medical Research Future Fund (MRF1141214). Laurie Zawertailo received funding from Canadian Institutes of Health Research, Canadian Cancer Society, Ontario Ministry of Health, and Global Research Awards in Nicotine Dependence. Flavio Frohlich received funding from NIH, Bran and Behavior Research Foundation, Human Frontiers Science Program, Tal Medical, and the Neurocare Group. Shirley Fecteau is supported by the Canada Research Chair in Cognitive Neuroplasticity. Stacey Daughters is supported by the NIH/NIDA (R01DA026424). Michael A. Nitsche receives funding from the German Research Foundation (DFG; SFB 1280 Project A6), and the German Federal Ministry of Education and Research (BMBF, GCBS grant 01EE1403C). Coleen A. Hanlon received funding from the NIDA (R01DA04447) and NIAAA (P50AA010761). Vincent Van Waes is supported by the Fondation pour la Recherche en Alcoologie (FRA) and the Région Bourgogne Franche-Comté. Ganesan Venkatasubramanian is supported by the Swarnajayanti Fellowship Grant (DST/SJF/LSA-02/2014-15) by the Department of Science and Technology, Government of India. Michael J. Wesley receives funding from the NIDA (K01DA043652; R01DA045023 and R01DA047368).
Publisher Copyright:
© 2019 Elsevier Ltd
PY - 2019/9/1
Y1 - 2019/9/1
N2 - There is growing interest in non-invasive brain stimulation (NIBS) as a novel treatment option for substance-use disorders (SUDs). Recent momentum stems from a foundation of preclinical neuroscience demonstrating links between neural circuits and drug consuming behavior, as well as recent FDA-approval of NIBS treatments for mental health disorders that share overlapping pathology with SUDs. As with any emerging field, enthusiasm must be tempered by reason; lessons learned from the past should be prudently applied to future therapies. Here, an international ensemble of experts provides an overview of the state of transcranial-electrical (tES) and transcranial-magnetic (TMS) stimulation applied in SUDs. This consensus paper provides a systematic literature review on published data – emphasizing the heterogeneity of methods and outcome measures while suggesting strategies to help bridge knowledge gaps. The goal of this effort is to provide the community with guidelines for best practices in tES/TMS SUD research. We hope this will accelerate the speed at which the community translates basic neuroscience into advanced neuromodulation tools for clinical practice in addiction medicine.
AB - There is growing interest in non-invasive brain stimulation (NIBS) as a novel treatment option for substance-use disorders (SUDs). Recent momentum stems from a foundation of preclinical neuroscience demonstrating links between neural circuits and drug consuming behavior, as well as recent FDA-approval of NIBS treatments for mental health disorders that share overlapping pathology with SUDs. As with any emerging field, enthusiasm must be tempered by reason; lessons learned from the past should be prudently applied to future therapies. Here, an international ensemble of experts provides an overview of the state of transcranial-electrical (tES) and transcranial-magnetic (TMS) stimulation applied in SUDs. This consensus paper provides a systematic literature review on published data – emphasizing the heterogeneity of methods and outcome measures while suggesting strategies to help bridge knowledge gaps. The goal of this effort is to provide the community with guidelines for best practices in tES/TMS SUD research. We hope this will accelerate the speed at which the community translates basic neuroscience into advanced neuromodulation tools for clinical practice in addiction medicine.
KW - Addiction
KW - NIBS
KW - Non-invasive brain stimulation
KW - Psychiatry
KW - Substance use disorder
KW - Transcranial electrical stimulation
KW - Transcranial magnetic stimulation
KW - rTMS
KW - tDCS
KW - tES
UR - http://www.scopus.com/inward/record.url?scp=85068939477&partnerID=8YFLogxK
U2 - 10.1016/j.neubiorev.2019.06.007
DO - 10.1016/j.neubiorev.2019.06.007
M3 - Review article
C2 - 31271802
AN - SCOPUS:85068939477
SN - 0149-7634
VL - 104
SP - 118
EP - 140
JO - Neuroscience and Biobehavioral Reviews
JF - Neuroscience and Biobehavioral Reviews
ER -
